Recent Quotes (30 days)

You have no recent quotes
chg | %

Concordia Healthcare Corp  

(Public, TSE:CXR)   Watch this stock  
Find more results for CXR
92.81
+0.72 (0.78%)
Apr 24 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 91.74 - 93.38
52 week 23.73 - 104.74
Open 91.74
Vol / Avg. 137,336.00/342,816.00
Mkt cap 3.06B
P/E 221.66
Div/yield 0.09/0.41
EPS 0.42
Shares 28.87M
Beta     -
Inst. own     -
May 15, 2015
Q1 2015 Concordia Healthcare Corp Earnings Call - 8:30AM EDT - Add to calendar
May 14, 2015
Q1 2015 Concordia Healthcare Corp Earnings Release - 4:00PM EDT - Add to calendar
Mar 20, 2015
Q4 2014 Concordia Healthcare Corp Earnings Call - Webcast
Mar 19, 2015
Q4 2014 Concordia Healthcare Corp Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 8.67% 9.49%
Operating margin 32.72% 28.51%
EBITD margin - 48.71%
Return on average assets 2.53% 3.04%
Return on average equity 5.82% 7.26%
Employees 214 -
CDP Score - -

Address

277 Lakeshore Rd E Suite 302
OAKVILLE, ON L6J 1H9
Canada
+1-905-8425150 (Phone)
+1-905-8425154 (Fax)

Website links

Description

Concordia Healthcare Corp. is a Canada-based diverse healthcare company. The Company is focused on legacy pharmaceutical products and orphan drugs. The Company operates through three segments, which includes Legacy Pharmaceutical Division, Concordia Pharmaceuticals Inc., which consists of 23 products, including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis; Donnatal, for the treatment of irritable bowel syndrome, and Zonegran (zonisamide), for treatment of partial seizures in adults with epilepsy. Its Specialty Healthcare Distribution (SHD) Division, Complete Medical Homecare, is engaged in the distribution of medical supplies focused on diabetes and related conditions. Its Orphan Drugs Division, Concordia Laboratories Inc., is engaged in the manufacture of PHOTOFRIN.

Officers and directors

Mark L. Thompson President, Chief Executive Officer, Founder, Director
Age: 46
Leith Tessy Chief Financial Officer, Treasurer, Secretary
Age: 52
Robert Altman Ph.D. President of Pinnacle
Age: 61
Wayne Kreppner Chief Operating Officer
Age: 41
John McCleery CPA Managing Director, Chief Financial Officer of CPI and CLI
Age: 56
Ronald D. Schmeichel J.D. Non-Executive Independent Chairman
Age: 47
Douglas N. Deeth Director
Age: 66
John-Michel T. Huss Independent Director
Age: 50
Jordan M. Kupinsky J.D. Independent Director
Age: 41